Capital Medical Center

Click Here to Subscribe!

E-Health Services

Daily Health News

  Latest News
  FDA Approvals
  FYI

Health Information

Newsletter Topics

Alzheimer's Disease
Anxiety
Arthritis
Blood Pressure
Breast Cancer
Cancer
Depression
Diabetes
Exercise / Fitness
Female Urological Disorders
Gastrointestinal Health
Healthy Diet
Heart Disease
Men's Health
Menopause
Neurology
Orthopedics
Pain Management
Parenting
Pediatrics
Pregnancy
Senior Caregiving
Seniors' Health
Sleep Disorders
Sports Medicine
Stroke
Weight Management
Women's Health
Women's Heart Health
Username: Password: Forgot password?
Remember me next time.
Newsletter

Men's Health
 
Anxiety May Lead to Unneeded Prostate Cancer Treatments...
SOURCE: University at Buffalo, news release, January 2017
1/27/2017

FRIDAY, Jan. 27, 2017 -- Anxiety may prompt prostate cancer patients to opt for potentially unnecessary treatments, a new study suggests.

The research included more than 1,500 men newly diagnosed with localized prostate cancer. They were more likely to choose surgery and radiation therapy...

Click here for full article »
Geneticists Get to the Roots of Hair Loss in Men...
SOURCE: PLOS Genetics, news release, Feb. 14, 2017
2/14/2017

TUESDAY, Feb. 14, 2017 -- Gene research may offer a glimmer of hope for men challenged by that bane of aging -- male-pattern baldness.

In the largest such study to date, a Scottish research team said it has identified close to 300 genetic regions tied to baldness. Previously, only a handf...

Click here for full article »
Hormonal Drug Boosts Survival After Prostate Cancer's Return: Study...
SOURCES: William Shipley, M.D., department of radiation oncology, Massachusetts General Hospital, and professor, radiation oncology, Harvard Medical School, Boston; Alexander Kutikov, M.D., associate professor, urologic oncology, Fox Chase Cancer Center, Philadelphia; Ashutosh Tewari, M.D., chair, urology, Icahn School of Medicine at Mount Sinai, New York City; Feb. 2, 2017, New England Journal of Medicine
2/1/2017

WEDNESDAY, Feb. 1, 2017 -- When prostate cancer recurs after surgery, treatment with both radiation and a testosterone-suppressing drug can extend some men's lives, a new clinical trial finds.

In a nearly 20-year study, researchers found that the combination therapy cut the risk of death ...

Click here for full article »
E-Home | E-Health Services | Sample News | Subscribe | Feedback | Contact Us | Privacy Policy | Terms & Conditions
 
© 2010 CAPITAL MEDICAL CENTER · 3900 CAPITAL MALL DRIVE SW · OLYMPIA, WA 98502 · 360-754-5858 · SITEMAP · PRIVACY POLICY · TERMS & CONDITIONS
 
ABOUT US SERVICES & TECHNOLOGY FOR PATIENTS & GUESTS FOR PHYSICIANS FOR EMPLOYEES COMMUNITY CAREERS